Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
J Appl Genet ; 65(2): 303-308, 2024 May.
Article in English | MEDLINE | ID: mdl-37987971

ABSTRACT

Noonan syndrome (NS; OMIM 163950) is an autosomal dominant RASopathy with variable clinical expression and genetic heterogeneity. Clinical manifestations include characteristic facial features, short stature, and cardiac anomalies. Variants in protein-tyrosine phosphatase, non-receptor-type 11 (PTPN11), encoding SHP-2, account for about half of NS patients, SOS1 in approximately 13%, RAF1 in 10%, and RIT1 each in 9%. Other genes have been reported to cause NS in less than 5% of cases including SHOC2, RASA2, LZTR1, SPRED2, SOS2, CBL, KRAS, NRAS, MRAS, PRAS, BRAF, PPP1CB, A2ML1, MAP2K1, and CDC42. Several additional genes associated with a Noonan syndrome-like phenotype have been identified. Clinical presentation and variants in patients with Noonan syndrome are this study's objectives. We performed Sanger sequencing of PTPN11 hotspot (exons 3, 8, and 13). We report molecular analysis of 61 patients with NS phenotype belonging to 58 families. We screened for hotspot variants (exons 3, 8, and 13) in PTPN11 gene by Sanger sequencing. Twenty-seven patients were carrying heterozygous pathogenic variants of PTPN11 gene with a similar frequency (41.4%) compared to the literature. Our findings expand the variant spectrum of Moroccan patients with NS phenotype in whom the analysis of hotspot variants showed a high frequency of exons 3 and 8. This screening test allowed us to establish a molecular diagnosis in almost half of the patients with a good benefit-cost ratio, with appropriate management and genetic counseling.


Subject(s)
Noonan Syndrome , Protein Tyrosine Phosphatase, Non-Receptor Type 11 , alpha-Macroglobulins , Humans , Exons , Intracellular Signaling Peptides and Proteins/genetics , Mutation , Noonan Syndrome/genetics , Noonan Syndrome/diagnosis , Noonan Syndrome/pathology , Phenotype , Protein Tyrosine Phosphatase, Non-Receptor Type 11/genetics , ras GTPase-Activating Proteins/genetics , Repressor Proteins/genetics , Transcription Factors/genetics
2.
Afr Health Sci ; 21(2): 960-967, 2021 Jun.
Article in English | MEDLINE | ID: mdl-34795756

ABSTRACT

BACKGROUND: Rubinstein-Taybi syndrome (RSTS; OMIM 180849) is a rare autosomal dominant developmental disorder with an estimated prevalence of one case per 125,000 live births. RSTS is characterized by typical face, broad thumbs and halluces, short stature, and intellectual disability. Facial dysmorphy is characteristic with microcephaly, low frontal hairline, arched eyebrows, long eyelashes, convex profile of nose, narrow palate, and micrognathia. RSTS is mainly due to mutations or microdeletions of the CREBBP gene (about 60%) and more rarely of the EP300 gene (8%). OBJECTIVE: Clinical description and identification of mutations of patients with Rubinstein Taybi syndrome. METHODS: PCR and direct sequencing of CREBBP gene. RESULTS: We report here, the clinical and molecular data of a series of six Moroccan patients with a phenotype of RSTS. The molecular study of the major gene CREBBP (by Sanger Sequencing followed by CGH array, if sequence normal) revealed point mutations in five patients. For the sixth patient, CGH array revealed a microdeletion carrying the CREBBP gene. Through this work, we emphasize the importance of clinical expertise in the diagnosis, management and genetic counseling in Rubinstein Taybi syndrome.


Subject(s)
Mutation , Rubinstein-Taybi Syndrome/genetics , Rubinstein-Taybi Syndrome/physiopathology , Child , Child, Preschool , Female , Humans , Infant , Male , Polymerase Chain Reaction
3.
BMC Med Genet ; 21(1): 240, 2020 12 12.
Article in English | MEDLINE | ID: mdl-33308164

ABSTRACT

BACKGROUND: In Morocco, consanguinity rate is very high; which lead to an increase in the birth prevalence of infants with autosomal recessive disorders. Previously, it was difficult to diagnose rare autosomal recessive diseases. Next Generation Sequencing (NGS) techniques have considerably improved clinical diagnostics. A genetic diagnosis showing biallelic causative mutations is the requirement for targeted carrier testing in parents, prenatal and preimplantation genetic diagnosis in further pregnancies, and also for targeted premarital testing in future couples at risk of producing affected children by a known autosomal recessive disease. METHODS: In this report, we present our strategy to advise a future couple of first cousins, whose descendants would risk cystinosis; an autosomal recessive lysosomal disease caused by mutations in the CTNS gene. Indeed, our future husband's sister is clinically and biochemically diagnosed with cystinosis in early childhood. First, we opted to identify the patient's CTNS gene abnormality by using (NGS), then we searched for heterozygosity in the couple's DNA, which allows us to predict the exact risk of this familial disease in the future couple's offspring. RESULTS: We have shown that the future husband, brother of the patient is heterozygous for the familial mutation. On the other hand, his future wife did not inherit the familial mutation. Therefore, genetic counseling was reassuring for the risk of familial cystinosis in this couple's offspring. CONCLUSIONS: We report in this study, one of the major applications of (NGS), an effective tool to improve clinical diagnosis and to provide the possibility of targeted premarital carrier testing in couples at risk.


Subject(s)
Amino Acid Transport Systems, Neutral/genetics , Consanguinity , Cystinosis/genetics , Genetic Counseling , Mutation , Adult , Amino Acid Transport Systems, Neutral/deficiency , Cystinosis/diagnosis , Cystinosis/pathology , Female , Gene Expression , Genetic Testing , Heterozygote , High-Throughput Nucleotide Sequencing , Humans , Male , Morocco , Pedigree , Risk
4.
J Med Case Rep ; 13(1): 266, 2019 Aug 23.
Article in English | MEDLINE | ID: mdl-31439038

ABSTRACT

BACKGROUND: Epilepsy is the most common neurological disorder that causes spontaneous, unprovoked, and recurrent seizures. Epilepsy is clinically and genetically heterogeneous with various modes of inheritance. The complexity of epilepsy presents a challenge and identification of the causal genetic mutation allows diagnosis, genetic counseling, predicting prognosis, and, in some cases, treatment decisions. Clinical exome sequencing is actually becoming a powerful approach for molecular diagnosis of heterogeneous neurological disorders in clinical practice. CASE PRESENTATION: We report our observations of three unrelated Moroccan patients referred to our genetics department for molecular diagnosis of epilepsy: a 4-year-old Moroccan boy, a 3-year-old Moroccan girl, and a 7-year-old Moroccan boy. Due to the heterogeneity and complexity of epilepsy, we performed clinical exome sequencing followed by targeted analysis of 936 epilepsy genes. A total of three mutations were identified in known epilepsy genes (SCN1A, SCN2A). By clinical exome sequencing, we identified two novel mutations: c.4973C>A (p.Thr1658Lys) in SCN1A gene and c.1283A>G (p.Tyr428Cys) in the SCN2A gene, whereas the third mutation c.3295G>T (p.Glu1099*) was already described in patients with Dravet syndrome. CONCLUSION: This study demonstrates that clinical exome sequencing is an effective diagnosis tool to investigate this group of diseases with huge diversity and defends its use in clinical routine.


Subject(s)
Epilepsy/genetics , Mutation , NAV1.1 Voltage-Gated Sodium Channel/genetics , NAV1.2 Voltage-Gated Sodium Channel/genetics , Child , Child, Preschool , Female , Heterozygote , Humans , Male , Morocco , Sequence Analysis, DNA , Exome Sequencing
5.
Cancer Genet ; 220: 49-76, 2018 01.
Article in English | MEDLINE | ID: mdl-29310839

ABSTRACT

Colorectal cancer (CRC) is very heterogeneous and presents different types of epigenetic alterations including DNA methylation, histone modifications and microRNAs. These changes are considered as characteristics of various observed clinical phenotypes. Undoubtedly, the discovery of epigenetic pathways with novel epigenetic-related mechanisms constitutes a promising advance in cancer biomarker discovery. In this review, we provide an evidence-based discussing of the current understanding of CRC epigenomics and its role in initiation, epithelial-to-mesenchymal transition and metastasis. We also discuss the recent findings regarding the potential clinical perspectives of these alterations as potent biomarkers for CRC diagnosis, prognosis, and therapy in the era of liquid biopsy.


Subject(s)
Colorectal Neoplasms/genetics , Colorectal Neoplasms/pathology , Epigenesis, Genetic , Epigenomics , Humans
6.
Eur J Med Genet ; 61(4): 189-196, 2018 Apr.
Article in English | MEDLINE | ID: mdl-29225145

ABSTRACT

Non-syndromic congenital hydrocephalus is aetiologically diverse and while a genetic cause is frequently suspected, it often cannot be confirmed. The most common genetic cause is L1CAM-related X-linked hydrocephalus and that explains only 5%-10% of all male cases. This underlines a current limitation in our understanding of the genetic burden of non-syndromic congenital hydrocephalus, especially for those cases with likely autosomal recessive inheritance. Additionally, the prognosis for most cases of severe congenital hydrocephalus is poor, with most of the surviving infants displaying significant intellectual impairment despite surgical intervention. It is for this reason that couples with an antenatal diagnosis of severe hydrocephalus are given the option, and may opt, for termination of the pregnancy. We present two families with CCDC88C-related recessive congenital hydrocephalus with children who had severe hydrocephalus. Those individuals who were shunted within the first few weeks of life, who did not require multiple surgical revisions, and who had a more distal truncating variant of the CCDC88C gene met their early childhood developmental milestones in some cases. This suggests that children with CCDC88C-related autosomal recessive hydrocephalus can have normal developmental outcomes under certain circumstances. We recommend CCDC88C analysis in cases of severe non-syndromic congenital hydrocephalus, especially when aqueduct stenosis with or without a medial diverticulum is seen, in order to aid prognosis discussion.


Subject(s)
Hydrocephalus/pathology , Intracellular Signaling Peptides and Proteins/genetics , Microfilament Proteins/genetics , Brain/diagnostic imaging , Brain/pathology , Child, Preschool , Female , Humans , Hydrocephalus/diagnostic imaging , Hydrocephalus/genetics , Hydrocephalus/surgery , Infant , Male , Prenatal Diagnosis
7.
Cytogenet Genome Res ; 153(2): 66-72, 2017.
Article in English | MEDLINE | ID: mdl-29248929

ABSTRACT

Unbalanced translocations involving X and Y chromosomes are rare and associated with a contiguous gene syndrome. The clinical phenotype is heterogeneous including mainly short stature, chondrodysplasia punctata, ichthyosis, hypogonadism, and intellectual disability. Here, we report 2 brothers with peculiar gestalt, short stature, and hearing loss, who harbor an X/Y translocation. Physical examination, brainstem acoustic potential evaluation, bone age, hormonal assessment, and X-ray investigations were performed. Because of their dysmorphic features, karyotyping, FISH, and aCGH were carried out. The probands had short stature, hypertelorism, midface hypoplasia, sensorineural hearing loss, normal intelligence as well as slight radial and ulnar bowing with brachytelephalangy. R-banding identified a derivative X chromosome with an abnormally expanded short arm. The mother was detected as a carrier of the same aberrant X chromosome. aCGH disclosed a 3.1-Mb distal deletion of chromosome region Xp22.33pter. This interval encompasses several genes, especially the short stature homeobox (SHOX) and arylsulfatase (ARSE) genes. The final karyotype of the probands was: 46,Y,der(X),t(X;Y)(p22;q12).ish der(X)(DXYS129-,DXYS153-)mat.arr[hg19] Xp22.33(61091_2689408)×1mat,Xp22.33(2701273_3258404)×0mat,Yq11.222q12 (21412851_59310245)×2. Herein, we describe a Moroccan family with a maternally inherited X/Y translocation and discuss the genotype-phenotype correlations according to the deleted genes.


Subject(s)
Abnormalities, Multiple/genetics , Arylsulfatases/genetics , Chromosomes, Human, X/genetics , Chromosomes, Human, Y/genetics , Hearing Loss, Bilateral/genetics , Hearing Loss, Sensorineural/genetics , Translocation, Genetic , Arylsulfatases/deficiency , Chromosomes, Human, X/ultrastructure , Chromosomes, Human, Y/ultrastructure , Consanguinity , Female , Humans , Hypertelorism/genetics , Infant, Newborn , Karyotyping , Male , Middle Aged , Morocco , Pedigree , Phenotype , Radius/abnormalities , Scoliosis/genetics , Siblings , Ulna/abnormalities , Young Adult
8.
J Med Case Rep ; 11(1): 158, 2017 Jun 15.
Article in English | MEDLINE | ID: mdl-28615033

ABSTRACT

BACKGROUND: Xeroderma pigmentosum is an autosomal recessive inherited disease. The diagnosis is essentially based on clinical findings and the family history. This genodermatosis is genetically heterogeneous; to date, nine genes have been associated to this disorder. Based on the result of many studies, xeroderma pigmentosum complementation group C is the most common form of xeroderma pigmentosum. A founder mutation in the XPC gene was reported in the Maghreb region of northern Africa. According to these findings, the Department of Medical Genetics in Rabat offers molecular diagnosis by screening for the recurrent mutation c.1643_1644delTG which represents 74% of all the probands with xeroderma pigmentosum. CASE PRESENTATION: We describe the case of a 21-year-old Moroccan son of consanguineous parents diagnosed with xeroderma pigmentosum on the basis of sun-exposed skin abnormalities and bilateral ocular involvement. A molecular study led to the identification of a new frameshift insertion of four nucleotides in exon 9. CONCLUSIONS: To the best of our knowledge, this mutation has not been described. The sequencing of the ninth exon should be proposed as first line molecular analysis for all Moroccan patients with xeroderma pigmentosum.


Subject(s)
Black People , DNA Mutational Analysis , DNA-Binding Proteins/genetics , Frameshift Mutation/genetics , Genetic Predisposition to Disease/genetics , Xeroderma Pigmentosum/genetics , Founder Effect , Genetic Predisposition to Disease/epidemiology , Humans , Male , Morocco , Prevalence , Xeroderma Pigmentosum/epidemiology , Young Adult
SELECTION OF CITATIONS
SEARCH DETAIL
...